Publication: Involvement of P2X7 receptor in neuronal degeneration triggered by traumatic injury
Authors
Nadal-Nicolás, Francisco Manuel ; Galindo Romero, Caridad ; Valiente Soriano, Francisco Javier ; Barberà-Cremades, María ; Torre-Minguela, Carlos de ; Salinas Navarro, Manuel Ángel ; Pelegrín Vivancos, Pablo ; Agudo Barriuso, Marta
item.page.secondaryauthor
Facultad de Medicina
item.page.director
Publisher
Nature Research
publication.page.editor
publication.page.department
DOI
https://doi.org/10.1038/srep38499
item.page.type
info:eu-repo/semantics/article
Description
Abstract
Axonal injury is a common feature of central nervous system insults that culminates with the death of the affected neurons, and an irreversible loss of function. Inflammation is an important component of the neurodegenerative process, where the microglia plays an important role by releasing proinflammatory factors as well as clearing the death neurons by phagocytosis. Here we have identified the purinergic signaling through the P2X7 receptor as an important component for the neuronal death in a model of optic nerve axotomy. We have found that in P2X7 receptor deficient mice there is a delayed loss of retinal ganglion cells and a decrease of phagocytic microglia at early times points after axotomy. In contralateral to the axotomy retinas, P2X7 receptor controlled the numbers of phagocytic microglia, suggesting that extracellular ATP could act as a danger signal activating the P2X7 receptor in mediating the loss of neurons in contralateral retinas. Finally, we show that intravitreal administration of the selective P2X7 receptor antagonist A438079 also delays axotomy-induced retinal ganglion cell death in retinas from wild type mice. Thus, our work demonstrates that P2X7 receptor signaling is involved in neuronal cell death after axonal injury, being P2X7 receptor antagonism a potential therapeutic strategy.
publication.page.subject
Citation
Sci Rep. 2016 Dec 8;6:38499
item.page.embargo
Collections
Ir a Estadísticas
Este ítem está sujeto a una licencia Creative Commons. http://creativecommons.org/licenses/by/4.0/